- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Allergy&Clinical Immunology
- Anesthesiology
- Business of Medicine
- Cardiology
- Critical Care
- Dental&Oral Health
- Dermatology
- Diabetes&Endocrinology
- Emergency Medicine
- Family Medicine/Primary Care
- Gastroenterology
- General Surgery
- Hematology-Oncology
- HIV/AIDS
- Hospital Medicine
- Infectious Diseases
- Internal Medicine
- Med Students
- Medscape Today
- Nephrology
- Neurology&Neurosurgery
- News
- News Alert
- None
- Nursing
- Ob/Gyn&Women's Health
- Ophthalmology
- Orthopaedics
- Pathology&Lab Medicine
- Pediatrics
- Pharmacist
- Plastic Surgery&Aesthetic Medicine
- Psychiatry
- Public Health&Prevention
- Pulmonary Medicine
- Radiology
- Rheumatology
- Transplantation
- Urology
September 1, 2022
Published by Med Search on September 1, 2022
Categories
CDRH IDE Expanded Access Requests (2014-2016)1 Expanded Access Totals FY 2014 FY 2015 FY 2016 Requested Received 218 222 136 Evaluable Requests2 212 211 124 Approved […]
September 1, 2022
Published by Med Search on September 1, 2022
Categories
[9/1/2022] FDA’s Center for Drug Evaluation and Research (CDER) is pleased to announce its partnership with the Critical Path Institute (C-Path) to explore the feasibility of […]
August 31, 2022
Published by Med Search on August 31, 2022
Categories
On This Page Date: October 11, 2022 Time: 8:50 AM – 3:10 PM ET Agenda Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
To enhance the security of the U.S. drug supply chain, FDA is: Preventing and reducing counterfeit and illegal online sales Instituting enhanced targeting and screening methods […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
To enhance the security of the U.S. drug supply chain, FDA is: Preventing and reducing counterfeit and illegal online sales Instituting enhanced targeting and screening methods […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
To expand therapy options, availability, and access, FDA is: Expanding availability and access to evidence-based treatments for substance use disorders Facilitating development of treatments for substance […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
To reduce morbidity and mortality associated with overdoses, FDA is: Expanding availability and access to overdose reversal products, including naloxone, by supporting accelerated review of products […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
To eliminate unnecessary initial exposure and inappropriate prolonged prescribing of substances with abuse potential, FDA is: Promoting appropriate prescribing of medications with abuse potential, including opioids, […]
August 30, 2022
Published by Med Search on August 30, 2022
Categories
Today, tens of millions of people in the United States depend on prescription and OTC medications to sustain their health—more than four billion prescriptions are written […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144
Next page